You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stroke,Fingolimod(FTY 720), treatment

Showing 1 - 25 of 8,940
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chemo-Induced Peripheral Neuropathy, Numbness, Pain Trial in Rochester, Columbus (Fingolimod, Fingolimod Hydrochloride,

Active, not recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • +3 more
  • Rochester, Minnesota
  • +1 more
Jan 17, 2023

Breast Carcinoma Trial in Rochester, Columbus, Richmond (Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration)

Active, not recruiting
  • Breast Carcinoma
  • Rochester, Minnesota
  • +2 more
Jul 6, 2022

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Enrolling by invitation
  • Interstitial Fibrosis
  • +6 more
  • Houston, Texas
    Houston Methodist Research Institute
Jan 23, 2023

Relapsing Multiple Sclerosis (RMS) Trial in China (Fingolimod 0.5mg)

Recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Fingolimod 0.5mg
  • Beijing, Beijing, China
  • +12 more
Feb 3, 2022

Multiple Sclerosis Trial in Belgium, Germany, Italy (Fingolimod)

Completed
Has Results
  • Multiple Sclerosis
  • Gent, Belgium
  • +3 more
Jan 21, 2021

Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of

Recruiting
  • Intracerebral Hemorrhage
  • +4 more
  • Fingolimod 0.5 mg
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Nov 28, 2022

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Little Rock, Arkansas
  • +55 more
Jan 13, 2023

Renal Insufficiency Trial in Moscow (fingolimod (FTY720))

Completed
  • Renal Insufficiency
  • fingolimod (FTY720)
  • Moscow, Russian Federation
    Novartis Investigator Site
Dec 6, 2020

Stroke, Vascular Accident, Cerebral Stroke Trial in Tianjin (Fingolimod)

Completed
  • Stroke
  • +4 more
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Oct 15, 2018

Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • Cullman, Alabama
  • +457 more
Mar 26, 2021

Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))

Recruiting
  • Multiple Sclerosis
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Jan 5, 2023

Relapsing Remitting Multiple Sclerosis RRMS Trial in Germany, Switzerland (Fingolimod)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis RRMS
  • Bochum, Germany
  • +9 more
Feb 14, 2020

Stroke Inflammation Trial in Fuzhou (Fingolimod)

Recruiting
  • Stroke Inflammation
  • Fuzhou, China
    The First Affiliated Hospital of Fujian Medical University
Apr 12, 2022

Relapsing Multiple Sclerosis Trial in United States (Fingolimod)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Birmingham, Alabama
  • +65 more
Oct 6, 2021

Intracerebral Hemorrhage Trial (Fingolimod)

Not yet recruiting
  • Intracerebral Hemorrhage
  • (no location specified)
Oct 17, 2023

Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

Recruiting
Has Results
  • Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Birmingham, Alabama
  • +106 more
Jan 13, 2023

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Cullman, Alabama
  • +165 more
Jan 13, 2023

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • La Jolla, California
  • +66 more
Jan 27, 2023

Acute Ischemic Stroke, Reperfusion, Large Vessel Occlusion Trial in Liuzhou, Changsha, Pingxiang (Y-6 sublingual tablets,

Not yet recruiting
  • Acute Ischemic Stroke
  • +2 more
  • Y-6 sublingual tablets
  • Placebo tablets of Y-6 sublingual tablet
  • Liuzhou, Guangxi, China
  • +2 more
Apr 19, 2023

Malaria Trial in Arzo (pyronaridine artesunate)

Completed
Has Results
  • Malaria
  • pyronaridine artesunate clinical trial reference tablets
  • pyronaridine artesunate to-be-marketed tablets
  • Arzo, Switzerland
    Cross Research S.A., Phase I Unit
Feb 1, 2023

Generic Fingolimod in Relapsing-Remitting Multiple Sclerosis in

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Alexandria, Egypt
  • +1 more
Jun 14, 2022

Uncontrolled Hypertension, Resistant Hypertension Trial in Worldwide (Baxdrostat, Placebo)

Not yet recruiting
  • Uncontrolled Hypertension
  • Resistant Hypertension
  • Saraland, Alabama
  • +122 more
Sep 6, 2023

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    Stroke, Inflammation Trial in Hangzhou (Fingolimod, Placebo)

    Unknown status
    • Stroke
    • Inflammation
    • Hangzhou, Zhejiang, China
      The second affiliated hospital of Zhejiang University
    Jul 17, 2021

    Multiple Sclerosis Treated Fingolimod or Other Approved

    Completed
    • Multiple Sclerosis
    • Birmingham, Alabama
    • +237 more
    Dec 28, 2021